Fate Therapeutics, Inc.Cash Flow Charts

8 quarters · ending 2025-12-31 · SEC EDGAR

Q1 2024
Q4 2025

Cash Flow Charts for Fate Therapeutics, Inc.

Capital Allocation

How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).

Capital Allocation Waterfall

Cash Flow

Cash Flow by Activity

Operating Cash Flow↓-1.4% -$459K
$-34M
Source:10-K · 10-Q